Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) insider Patrick A. Cunningham sold 18,500 shares of the business's stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $4.93, for a total transaction of $91,205.00. Following the completion of the transaction, the insider now owns 327,869 shares of the company's stock, valued at $1,616,394.17. The trade was a 5.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.
Aveanna Healthcare Trading Down 3.3%
NASDAQ AVAH traded down $0.17 on Friday, hitting $4.91. 437,916 shares of the company were exchanged, compared to its average volume of 326,171. The company has a market cap of $957.91 million, a PE ratio of -14.44 and a beta of 2.03. Aveanna Healthcare Holdings Inc. has a 12 month low of $2.32 and a 12 month high of $6.19. The stock has a fifty day moving average of $5.09 and a 200-day moving average of $4.92.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on the stock. Truist Financial decreased their price target on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a report on Friday, April 11th. UBS Group boosted their target price on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the stock a "sell" rating in a report on Friday, May 9th.
Get Our Latest Report on Aveanna Healthcare
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of AVAH. Price T Rowe Associates Inc. MD raised its holdings in Aveanna Healthcare by 5.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 53,699 shares of the company's stock worth $246,000 after buying an additional 2,649 shares during the last quarter. Rhumbline Advisers boosted its position in shares of Aveanna Healthcare by 4.0% in the first quarter. Rhumbline Advisers now owns 75,581 shares of the company's stock valued at $410,000 after acquiring an additional 2,918 shares during the period. Charles Schwab Investment Management Inc. lifted its position in Aveanna Healthcare by 0.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company's stock valued at $2,133,000 after purchasing an additional 4,047 shares during the last quarter. MetLife Investment Management LLC lifted its position in Aveanna Healthcare by 16.2% during the first quarter. MetLife Investment Management LLC now owns 31,251 shares of the company's stock valued at $169,000 after purchasing an additional 4,349 shares during the last quarter. Finally, AQR Capital Management LLC lifted its position in Aveanna Healthcare by 21.2% during the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company's stock valued at $142,000 after purchasing an additional 4,602 shares during the last quarter. 87.96% of the stock is owned by institutional investors.
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.